Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine Besilate / Nebivolol Hydrochloride, the active ingredient in Nesyrgy, is a calcium channel blocker and beta‑blocker combination presented as an oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Nesyrgy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nesyrgy combines a calcium channel blocker and a beta‑blocker to manage elevated blood pressure.

Hypertension: reduces systolic and diastolic blood pressure in adult patients with primary hypertension.

Common Side Effects: - Peripheral edema: mild swelling of the ankles or feet. - Headache: transient throbbing pain, often related to vasodilation. - Flushing: warmth and redness of the skin, especially on the face. - Dizziness: sensation of light‑headedness, particularly after standing. - Fatigue: general tiredness without exertion. - Nasal congestion: mild blockage of nasal passages.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Bradycardia: unusually slow heart rate that can lead to dizziness or syncope. - Heart block: impaired electrical conduction requiring medical attention. - Liver enzyme elevation: abnormal liver function tests indicating possible hepatic stress. - Angio‑edema: rapid swelling of lips, tongue, or throat that can compromise breathing. - Allergic reaction: rash, itching, or swelling indicating hypersensitivity.

Before initiating therapy, clinicians should consider individual patient factors and monitor for adverse reactions. - Blood pressure monitoring: check regularly to ensure therapeutic targets are met. - Cardiac assessment: evaluate heart rate and rhythm, especially in patients with pre‑existing conduction disorders. - Gradual dose changes: avoid abrupt discontinuation to prevent rebound hypertension. - Hepatic function: adjust use in patients with moderate to severe liver impairment. - Drug‑specific counseling: advise patients to rise slowly to reduce orthostatic symptoms. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nesyrgy may interact with other medicines that affect blood pressure or drug metabolism.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase amlodipine exposure. - Non‑selective beta‑blockers (e.g., propranolol): additive bradycardia and hypotension. - Other antihypertensives (e.g., ACE inhibitors, ARBs): risk of excessive blood pressure lowering.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive effect, requiring dose adjustment. - Digoxin: nebivolol can increase serum digoxin levels. - Moderate CYP3A4 inhibitors (e.g., clarithromycin, erythromycin): may modestly raise amlodipine concentrations. - Antidiabetic agents: blood glucose may fall, necessitating closer monitoring. - NSAIDs: can blunt antihypertensive response, especially in sodium‑retaining individuals.